Evidence map›Paper›PMID 42681150›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

Expression of Recombinant Collagen Domains and Matrikines in Eukaryotic Cells.

Sylvain D Vallet, Romain Salza, Sylvie Ricard-Blum

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sylvain D ValletICBMS, UMR 5246 CNRS, University Lyon 1, Villeurbanne, Cedex, France.
Romain SalzaScience Nature Technology ACQUA.ecologie, Ecosite, Mèze, France.
Sylvie Ricard-BlumICBMS, UMR 5246 CNRS, University Lyon 1, Villeurbanne, Cedex, France. sylvie.ricard-blum@univ-lyon1.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The expression of extracellular matrix protein domains, which exhibit biological activities of their own, is required in order to get a sufficient amount to perform experiments aiming at determining their structure, interactions, and functions, and for preclinical and clinical studies. We describe here the protocol we designed to express in human embryonic kidney cells a recombinant von Willebrand factor A domain of human collagen VI, and recombinant anti-angiogenic matrikines of human collagens VIII (vastatin) and XVIII (endostatin).

Indexed as

CollagenCollagen Type VIIICollagen Type XVIIIEukaryotic CellsExtracellular Matrix ProteinsGene ExpressionRecombinant ProteinsEndostatinsHEK293 CellsHumansProtein DomainsCollagenCollagen Type VIIICollagen Type XVIIIEndostatinsExtracellular Matrix ProteinsRecombinant ProteinsCollagenDomainsEndostatinEukaryotic cellsExtracellular matrixMatricryptinsMatrikinesRecombinant proteinsVastatinVon Willebrand Factor A domain

Identifiers

PMID42681150

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.